When Lumen was founded it was a research-stage biotech with an ambitious thesis and no commercial products. What it did have was a conviction that its digital infrastructure had to be foundational, not an afterthought. Leadership engaged Oraya® to build an integrated finance and supply chain platform — a digital core that would scale further than anyone expected.
When demand for Lumen’s therapies accelerated, that foundation didn’t just hold, it scaled. The company went from pre-commercial to multi-billion-dollar revenue in a short period, mobilizing global supply chains and meeting international serialization requirements along the way.
Challenges
As Lumen moved from research to global manufacturing, it faced operational demands that would have overwhelmed systems built for a smaller scale:
- Rapidly standing up global supply chains to support manufacturing and distribution
- International serialization and traceability requirements in every market
- Seamless integration across finance, procurement, manufacturing and supply chain
- Secure data exchange with partners across multiple regulatory regimes
- Scaling digital infrastructure at the pace of the business, without disruption
Why Oraya
Lumen’s founders made a deliberate early choice: digitalization from the ground up was a requirement, not an option. Rather than deploy point solutions, the company chose a long-term platform — and a partner with deep life sciences experience.
“We knew from day one that the platform had to grow faster than our headcount. The foundation they built is still carrying us.”
— SVP Finance, Lumen Biotherapeutics
Implementation highlights
- A single digital core for finance, supply chain and procurement
- Integrated procurement, travel, contingent workforce and learning applications
- Serialization and track-and-trace capabilities for global compliance
- Integrations with manufacturing execution, lab systems and HR platforms
- A phased rollout that expanded capability without disrupting operations
Outcome
The platform proved its value not only at launch, but at a scale no one had planned for. Lumen is now recognized as a leading digital biotech — one whose ability to move from lab to global scale was built, in part, on the foundation Oraya helped establish.
